PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosisClaudia Augello, Silvia Maria Sirchia, Umberto Gianelli et al.|Leukemia Research|2014Cited by 11
<i>DPYD</i> -Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective StudyFrancesco Schettini, Daniele Generali, Carla Strina et al.|JCO Precision Oncology|2026Cited by 0